Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PURE BIOSCIENCE, INC. (PURE)
|
Add to portfolio |
|
|
|
| Price: |
$0.22
| | Metrics |
| OS: |
111.4
|
M
| |
|
|
| Market cap: |
$25
|
M
| |
|
|
|
Net cash:
|
$1.48
|
M
| |
$0.01
|
per share
|
|
EV:
|
$23.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jul-31-21 | Jul-31-20 | Jul-31-19 | Jul-31-18 | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 |
| Revenues | 3.9 | 6.9 | 1.9 | 1.8 | 2.6 | 1.3 | 0.7 | 0.6 |
| Revenue growth | -43.2% | 262.3% | 7.6% | -31.5% | 101.0% | 76.8% | 32.5% | -32.9% |
| Cost of goods sold | 1.9 | 2.9 | 0.7 | 0.8 | 0.8 | 0.4 | 0.3 | 0.3 |
| Gross profit | 2.1 | 4.0 | 1.2 | 1.0 | 1.8 | 0.8 | 0.4 | 0.2 |
| Gross margin | 52.8% | 58.1% | 61.9% | 57.0% | 70.7% | 65.8% | 60.9% | 37.5% |
| Selling, general and administrative | 4.0 | 3.7 | 6.4 | 5.2 | 5.2 | 5.1 | 4.9 | 5.1 |
| Research and development | 0.3 | 0.3 | 0.4 | 0.5 | 0.8 | 0.9 | 0.8 | 1.0 |
| EBITA | -2.2 | 0.1 | -5.5 | -6.9 | -5.8 | -7.1 | -7.6 | -11.7 |
| EBITA margin | -56.9% | 1.1% | -285.7% | -386.9% | -225.0% | -547.5% | -1048.0% | -2121.8% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | | | 0.2 |
| EBIT | -2.3 | 0.0 | -5.6 | -7.0 | -6.0 | -7.1 | -7.6 | -11.8 |
| EBIT margin | -58.8% | 0.1% | -292.8% | -397.0% | -231.9% | -547.5% | -1048.0% | -2154.0% |
| Pre-tax income | -2.3 | 0.0 | -6.6 | -7.4 | -6.3 | -14.4 | -7.6 | -11.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 29.2% | | | | | | 0.0% |
| Net income | -2.3 | 0.0 | -6.6 | -7.4 | -6.3 | -14.4 | -7.6 | -11.1 |
| Net margin | -59.1% | 0.1% | -343.3% | -419.5% | -241.7% | -1114.9% | -1046.2% | -2009.1% |
| |
| Diluted EPS | ($0.03) | $0.00 | ($0.09) | ($0.11) | ($0.10) | ($0.25) | ($0.19) | ($0.43) |
| Shares outstanding (diluted) | 87.2 | 84.6 | 72.9 | 67.3 | 63.5 | 56.8 | 39.7 | 25.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|